Residual Nodal Burden After Neoadjuvant Systemic Therapy in N2-N3 Her2+ and Triple Negative Breast Cancer
Triple-negative breast cancer
Neoadjuvant Therapy
Systemic therapy
DOI:
10.1016/j.ejso.2023.107435
Publication Date:
2024-02-23T23:55:53Z
AUTHORS (11)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....